Ruben Carrasco
Associate Professor of Pathology, Harvard Medical School · Mass General Brigham
Credentials: · · · · ·
History
- Present
- 1999–2000
Hematology
- 1982–1985
Internal Medicine
Research
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Review · Leukemia · 2009 · 680 citations
Cancer Cell · 2012 · 518 citations
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Nature · 2017 · 463 citations
35 papers
27 papers
17 papers
12 papers
10 papers
10 papers · 1 as a fellow
7 papers · 2 as a fellow
6 papers
Grants
- 2022–2027
Investigating and Modeling MYD88L265P and Co-Occurring Mutations in Mature B-Cell Malignancies
National Cancer Institute · R01
Contact PI · $2.2M · Dana-Farber Cancer Inst
- 2021–2027
Development of microRNA (miR)-Based Cell-Targeted Polymeric Nanoparticles for Myeloma Therapy
National Cancer Institute · R01
Contact PI · $2.7M · Dana-Farber Cancer Inst
- 2016–2026
Comprehensive Dissection of the CLL Genome & Phenome to Improve Patient Outcomes
National Cancer Institute · P01
Project lead · $570.9K · Dana-Farber Cancer Inst
- 2015–2021
Validating the eCyPA/CD147 Signaling Complex for Myeloma Therapy
National Cancer Institute · R01
Contact PI · $2M · Dana-Farber Cancer Inst